[Drosophila as a new model system for leukaemia].
Dani
D
Osman
Vanessa
V
Gobert
Marc
M
Haenlin
Lucas
L
Waltzer
D000818:Animals; D030801:Animals, Genetically Modified; D002154:Calpain / Q000502:physiology; D002478:Cells, Cultured / Q000378:metabolism; D050676:Core Binding Factor Alpha 2 Subunit / Q000502:physiology*; D004268:DNA-Binding Proteins / Q000502:physiology; D004195:Disease Models, Animal; D029721:Drosophila Proteins / Q000502:physiology; D004331:Drosophila melanogaster / Q000166:cytology*; D015973:Gene Expression Regulation, Leukemic; D005804:Genes, Lethal; D006434:Hemocytes / Q000378:metabolism*; D015470:Leukemia, Myeloid, Acute / Q000235:genetics*; D015514:Oncogene Proteins, Fusion / Q000502:physiology*; D010641:Phenotype; D011289:Preleukemia / Q000473:pathology; D011499:Protein Processing, Post-Translational; D011679:Pupa; D000075142:RUNX1 Translocation Partner 1 Protein; D014157:Transcription Factors / Q000502:physiology
C107844:AML1-ETO fusion protein, human; D050676:Core Binding Factor Alpha 2 Subunit; D004268:DNA-Binding Proteins; D029721:Drosophila Proteins; D015514:Oncogene Proteins, Fusion; D000075142:RUNX1 Translocation Partner 1 Protein; D014157:Transcription Factors; C099964:lz protein, Drosophila; D002154:Calpain